Cargando…

Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma

BACKGROUND: Bladder carcinoma (BLCA) is a heterogeneous disease that makes it difficult to achieve proper individual treatment and predict prognosis. This study aimed to develop a risk score from a new perspective of pyroptosis and guide accurate treatment and prognosis prediction for BLCA. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Dingshan, Liu, Fenglian, Liu, Zhi, Wu, Zuowei, He, Yunbo, Zhang, ChunYu, Zu, Xiongbin, Ou, Zhenyu, Wang, Yongjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450692/ https://www.ncbi.nlm.nih.gov/pubmed/36090967 http://dx.doi.org/10.3389/fimmu.2022.965469

Ejemplares similares

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
por: Xiao, Zicheng, et al.
Publicado: (2022)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
por: Zhang, Chunyu, et al.
Publicado: (2023)

A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
por: Deng, Dingshan, et al.
Publicado: (2023)

ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts
por: Li, Zhiwei, et al.
Publicado: (2023)

Pyroptosis-related signatures in bladder cancer prognosis and treatment—are we there yet?
por: Kołat, Damian, et al.
Publicado: (2022)

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8(+) T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2023)

Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer
por: Lu, Zechao, et al.
Publicado: (2022)

A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer
por: Chen, Weikang, et al.
Publicado: (2021)

The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
por: Hu, Lin, et al.
Publicado: (2022)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
por: Liu, Jinhui, et al.
Publicado: (2023)

Pyroptosis-Related Gene Signatures Can Robustly Diagnose Skin Cutaneous Melanoma and Predict the Prognosis
por: Ju, Anji, et al.
Publicado: (2021)

An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts
por: Deng, Hao, et al.
Publicado: (2023)

Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer
por: Zhuang, Zhicheng, et al.
Publicado: (2021)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
por: Cai, Zhiyong, et al.
Publicado: (2023)

Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
por: Jiang, Zhengsong, et al.
Publicado: (2023)

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
por: Li, Huihuang, et al.
Publicado: (2022)

Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer
por: Zhou, Kexun, et al.
Publicado: (2022)

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Pyroptosis-Related Signatures for Predicting Prognosis in Breast Cancer
por: Ren, Tong, et al.
Publicado: (2022)

Pyroptosis correlates with tumor immunity and prognosis
por: Lou, Xiaoying, et al.
Publicado: (2022)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
por: Zhang, Dengfeng, et al.
Publicado: (2023)

Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer
por: Zhao, Jiahui, et al.
Publicado: (2022)

Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
por: Pan, Jingjing, et al.
Publicado: (2022)

A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma
por: Zhang, Zhan-Fei
Publicado: (2023)

Identification of pyroptosis-related signature for cervical cancer predicting prognosis
por: Zhou, Cankun, et al.
Publicado: (2021)

Predicting the prognosis of glioma by pyroptosis‐related signature
por: Chao, Bo, et al.
Publicado: (2021)

Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
por: Ou, Zhenyu, et al.
Publicado: (2015)

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
por: Hu, Jiao, et al.
Publicado: (2022)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer
por: Wu, Tielin, et al.
Publicado: (2022)

Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2019)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n283vgljlun4tgqiujehvslnf3